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Abstract
Objective: Animal model studies have shown that MSY2 and JHDM2A genes have an 
important role in spermatogenesis process and fertility of male mice. But the potential 
role of these genes in human spermatogenesis and fertility is not known yet.  Therefore, 
we evaluated expression ratios of these genes in testis tissues of men with normal and 
impaired spermatogenesis.
Materials and Methods: In this experimental study, after RNA extraction and cDNA syn-
thesis from 50 non-obstructive azoospermic and 12 normal testis tissues, the expression 
ratios of genes were evaluated by real time polymerase chain reaction (PCR) technique. 
Hematoxcylin and eosin (H&E) staining was used for histological classification of testis tis-
sues. For statistical analysis, one way analysis of variance (ANOVA) test was carried out.
Results: Our results showed a significant reduction in mRNA level of YBX2 in samples 
with impaired spermatogenesis (p<0.001) compared to samples with qualitatively nor-
mal spermatogenesis and normal spermatogenesis; however, in JHDM2A gene, despite 
sensible reduction in gene expression level in men with impaired spermatogenesis, no 
significant differences were shown (p>0.05). Furthermore in YBX2, a significant negative 
correlation was demonstrated between the efficiency score of spermatogenesis and the 
threshold cycle (CT) (r=-0.7, p<0.0001), whereas in JHDM2A, this negative correlation 
was not significant (r=-0.4, p=0.06).          
Conclusion: Generally, these data indicated that YBX2 and JHDM2A genes may play 
an important role in male infertility, and suggested that these molecules can act as 
useful biomarkers for predicting male infertility.          
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Introduction
YBX2 and JHDM2A genes are germ-cell-specific 
molecules which are essential for the production 
of functional spermatozoa; therefore, their inacti-
vation could lead to male infertility. Y box binding 
protein 2 (YBX2), also known as Contrin, is a hu-
man homologue of Xenopus DNA/RNA-binding 
and mouse MSY2 proteins (1, 2). The gene encod-
ing Contrin or YBX2 is located on human chro-
mosome 17p11.2-13.1. This gene appears to be 
testis-specific and distinct from other mammalian 
Y-box-binding proteins (3). In the mouse testis, 
this gene is expressed from pachytene spermato-
cyte to late spermatid stages, but the active form of 
YBX2 factor is in round spermatid stage (4). YBX2 
protein is highly similar to its mouse and xenopus 
germ-cell Y-box protein homologues. YBX2 also 
acts as an mRNA stabilizer and a transcription fac-
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tor of some testis specific genes such as protamine 
genes. Consequently, its loss of expression is like-
ly to contribute to the nuclear condensation defects 
that occur in MSY2-null late-stage spermatids (4-
6). Histone H3 lysine 9 (H3K9) methylation is 
one of the best-characterized modifications in the 
study of germ cell development, such as meiotic 
chromosomal recombination, segregation, and his-
tone removal followed by chromatin condensation 
in spermiogenesis.
In order to do these processes, simultaneous 
function of methyltransferase and demethylase 
enzymes is unavoidable (7). JmjC-containing 
histone demethylase 2a (JHDM2A), also known 
as JMJD1A or KDM3A, has been identified as 
an H3K9 demethylase (for monomethylation 
and dimethylation), while it has been originally 
cloned as a testis-specific gene transcript (7). 
Location of this gene on human chromosome 
is 2p11.2. JHDM2A specifically regulates the 
expression of the genes encoding transition 
protein 1 (Tp1) and protamine proteins, while 
this gene is necessary for the proper chromatin 
reorganization during spermatid maturation by 
directly promoting the transcription of the tran-
sition nuclear protein 1 (TNP1) and protamine1 
(PRM 1) genes (8, 9). Since both of two candi-
date genes in this research involve in expression 
regulation of some testis specific and important 
genes such as PRM1, PRM2, TNP1, TNP2, etc., 
different studies have pointed out that targeting 
YBX2 and JHDM2A  genes in animal models 
causes male infertility and different degrees of 
impaired spermatogenesis. To access this fact, 
for the first time, we evaluated the expression 
level of these genes in testicular tissues of men 
with non-obstructive azoospermia, with differ-
ent class of spermatogenesis.
Materials and Methods
Testicular tissue 
This experimental study was approved by the 
Ethical Committee of the Faculty of Medical Sci-
ences of Qazvin University of Medical Sciences, 
Qazvin, Iran. Sampling was done under supervi-
sion of urologist in Fertility and Infertility Center 
of Shariati Hospital., Tehran, Iran, during 2012. 
After patients gave an informed written consent, 
testicular biopsies were obtained from 50 azoo-
spermic men with mean age of 31.3 ± 3.7 years 
old; these patients were candidates of assisted 
reproductive technique (ART) and exhibited im-
paired spermatogenesis. In 12 patients with ob-
structive azoospermia after vasectomy, biopsies 
were carried out for diagnostic reasons during va-
sectomy reversal. These biopsies revealing normal 
spermatogenesis were served as controls, while the 
mean age of these individuals was 35 ± 2.9 years 
old. The limitation of this study was scarcity of tis-
sue samples with normal spermatogenesis, for this 
reason sampling time was prolonged.
To decrease possible confounding factors, the 
patients were excluded for these criteria: Y chro-
mosome microdeletion, cystic fibrosis, varicocele, 
Klinefelter syndrome, or exposure to chemothera-
py and radiation. In infertile patients with non-ob-
structive azoospermia, one part of testicular tissue 
specimens was used for testicular sperm extrac-
tion, while the other part was cut into two pieces; 
one piece was immediately prepared and frozen 
for RNA extraction procedure, and the other piece 
was fixed in Bouin’s fixative (Sigma, USA) and 
embedded in paraffin.
For histological evaluation, 5-µm-thick paraf-
fin sections were stained in hematoxylin and eosin 
(H&E), and then scored according to the modified 
Johnsen scoring system. In this system of classi-
fication, all tubular sections in each piece of the 
testicular biopsy are evaluated systematically, and 
each is given a score from 1 to 10 as follows: score 
10 including complete spermatogenesis with many 
spermatozoa; score 9 including slightly impaired 
spermatogenesis, many late spermatids, and disor-
ganized epithelium; score 8 including less than five 
spermatozoa per tubule and few late spermatids; 
score 7 including no spermatozoa, no late sperma-
tids and many early spermatids; score 6 including 
no spermatozoa, no late spermatids and few early 
spermatids; score 5 including no spermatozoa or 
spermatids and many spermatocytes; score 4 in-
cluding no spermatozoa or spermatids and few 
spermatocytes; score 3 including only spermato-
gonia; score 2 including no germinal cells andSer-
toli cells only; as well as score 1 no seminiferous 
epithelium (10). To follow this classifying method, 
our samples were divided into 3 main groups based 
on above scoring: normal spermatogenesis (score 
10), qualitatively normal spermatogenesis (scores 
8-9), and impaired spermatogenesis (scores 1-7) 
(Table 1).
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Table 1: Characterization of patient groups I-III and results of quantitative PCR analysis
Group 3Group 2Group 1Histological classification 
Impaired spermatogenesisQualitatively normal spermatogenesisNormal spermatogenesis
1-78-910Scores
341612Number of  patients
24.1 ± 1.921.2 ± 0.9921.75 ± 1.2Ct YBX2 (mean ± SD)
23.12 ± 2.323.1± 1.123.6 ± 0.85Ct GAPDH (mean ± SD)
0.5 ± 0.73.7 ± 1.53.6 ± 1.82-ΔCt
27 ± 1.726.33 ± 1.125.9 ± 0.96Ct JHDM2A (mean ± SD)
24.5 ± 1.224.3 ± 1.423.95 ± 1.5Ct GAPDH (mean ± SD)
0.17 ± 0.10.24 ± 0.150.25 ± 0.192-ΔCt
PCR: Polymerase chain reaction and SD; Standard deviation.
RNA extraction and first strand cDNA synthesis   
In summary, frozen testis tissues are homog-
enized in lysis buffer (Qiagen, Germany) using 
an ultrasonic processor UP100H (100W, 30 kHz) 
(Hielsher, Germany), and RNA is then extracted 
using RNeasy Mini Kit (Qiagen, Germany). In 
this regard, 1 volume of 70% ethanol was added 
to the homogenized lysate, and up to 700 μl of 
the sample was then transferred to an RNeasy 
spin column placed in a 2 ml collection tube. We 
used column DNase digestion to remove the re-
sidual DNA. After using different washing buff-
ers, the RNeasy spin column was placed in a new 
1.5 ml collection tube, 30-50 μl RNase-free water 
was added directly to the spin column membrane 
to elute the RNA, and finally RNA was frozen at 
-80˚C. Quality and quantity of isolated total RNA 
was measured using Nano Drop 2000c (Thermo, 
USA). In this case, RNA samples with A260/A280 
ratios of >2 were selected for quantitative analy-
sis. First strand complementary DNA (cDNA) 
synthesis was also performed using the RevertAid 
First Strand cDNA Synthesis Kit (Thermo Scien-
tific, Fermentas, Waltham, MA, USA). For cDNA 
synthesis, 1-5 µg total RNA and 0.5 µg oligo (dt) 
were added to sterile, nuclease-free tube on ice, 
and total volume reached to 11.5 µl with DEPC-
treated water. This solution was mixed and centri-
fuged briefly and then was incubated at 65˚C for 5 
minutes. Next 4 μl 5X reaction buffer for reverse 
transcription, 0.5 μl RiboLock™ RNase inhibi-
tor, 2 μl dNTP mix and 1 μl revertaid™ H minus 
reverse transcriptase (Bioneer, Korea) were add-
ed to solution, and total volume reached to 25 
μl with DEPC-treated water. After being centri-
fuged, the solution was incubated for 60 minutes 
at 42˚C. Ultimately the reaction was terminated 
by heating at 70˚C for 10 minutes.
Real-time polymerase chain reaction (PCR) and 
comparative threshold cycle (CT) method   
In this experiment, we used GAPDH gene as an 
internal control for quantification of target genes 
expression. Two target genes (YBX2 and JHDM2A) 
and GAPDH (as internal control) were amplified 
with appropriate primers and probes (Table 2). All 
primers and probes were designed using gene run-
ner software version 3.05 (Hastings SoftwareInc. 
Hastings, NY, USA). TaqMan real time PCR assay 
was carried out in final reaction volumes of 20 µl 
with 10 µl of a TaqManMaster Mix (Takara, Shi-
ga, Japan), 0.2 μM of forward and reverse primers, 
and 2 μl of cDNA. Thermal cycling was performed 
using the ABI-7500 sequence detection system 
(Applied Biosystems, Foster, CA, USA) with the 
following cycling condition: 30 seconds at 95˚C 
as first denaturation step, followed by 40 cycles at 
95˚C for 5 seconds and 60˚C for 34 seconds. 
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Table 2: The oligonucleotid primers and probes used in real time PCR assay
Amplicon size SequenceTarget and internal (bp) control genes
150F: CCCTACCCAGTACCCTGCTYBX2
R: CCTTCCTTCAACCCTTGATAA
P: CAGGAGGACCAAAGCAGCAGCC
145F: GTTCCACAAGCATTGACTGGJHDM2A
R: CTGGTGCATTTGAAACATCC
P: TGCCAATCCTCCTGAACTGCAGA
93F: TCAAGAAGGTGGTGAAGCAGGAPDH
R: CGCTGTTGAAGTCAGAGGAG
P: CCTCAAGGGCATCCTGGGCT 
PCR: Polymerase chain reaction.
Optimization of real-time PCR assay 
The efficiency of each gene was determined 
using 10 fold series of normal cDNA dilutions. 
Validation of experiments was performed to de-
termine PCR efficiencies of target and reference 
gene. The slopes of the fit lines were within the 
acceptable range of -3.6<slope<-3.1. PCR effi-
ciencies of target genes and reference gene were 
approximately equal, indicating validity of the 
comparative threshold cycle method for quanti-
fying the expression. Each assay was repeated at 
least two times before drawing any conclusions. 
The 2−ΔCT method of relative quantification was 
used to determine the fold change in expression. 
This was done by normalizing the resulting CT 
values of the target mRNAs to the CT values of 
the internal control () in treated and untreated 
samples (ΔCT=CTtarget–CTGAPDH) (11).
Statistical analysis 
Statistical analysis including mean, standard de-
viation (SD), and correlation coefficients (R) were 
done using Prism (version 3) software (GraphPad 
Prism, California, USA).
Additionally, one-way analysis of variance (ANO-
VA) was carried out to determine the significant dif-
ferences between the studied groups. A p value of 
<0.05 was considered as statistically significant.
Results
Men with impaired spermatogenesis (group III) 
exhibited a significant (p<0.001) lower mRNA 
level of YBX2 (2-ΔCt: 0.5 ± 0.7) when compared 
to the samples with normal spermatogenesis 
(group I) (2-ΔCt: 3.6 ± 1.8) and qualitatively 
normal spermatogenesis (group II) (2-ΔCt: 3.03 
± 1.5). In the testicular tissues of azoospermic 
men with impaired spermatogenesis, YBX2 
transcripts were 7.2 folds less than testicular 
tissues of men with normal spermatogenesis 
(Fig.1), but there is no significant difference 
in mRNA ratio (2-ΔCt) of YBX2 between the 
samples of group I and group II (p>0.05). The 
mRNA content of JHDM2A in testis tissues of 
studied groups showed that despite sensible re-
duction in gene expression in samples with im-
paired spermatogenesis (2-ΔCt: 0.17 ± 0.1), com-
pared to samples with normal and qualitatively 
normal spermatogenesis (2-ΔCt: 0.25 ± 0.19 and 
2-ΔCt: 0.24 ± 0.15, respectively), there was no 
significant difference in 2-ΔCt ratio among the 
three studied groups (p>0.05, Fig.2). A signifi-
cant negative correlation could be seen between 
the efficiency score of spermatogenesis and the 
mean CT value of mRNA level of YBX2 (r=-0.7, 
p<0.0001), whereas in JHDM2A, this negative 
correlation was not significant (r=-0.4, p=0.06, 
Fig.3A, B).
Generally, a negative correlation could be seen 
between the efficiency of spermatogenesis in dif-
ferent studied groups, in a way that down regula-
tion of YBX2 was seen significantly in comparison 
to normal ones in groups with different levels of 
impaired spermatogenesis (Fig.4).
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Fig.1: mRNA expression of YBX2. Men with normal spermatogenesis (n=12, score 10), men with qualitatively normal spermatogenesis 
(n=16, scores 8-9) and in azoospermic men with impaired spermatogenesis (n=34, scores 1-7). Values are presented as mean ± SD. **; 
P<0.001 as compared to control groups using one way ANOVA test. 
SD; Standard deviation and ANOVA; One-way analysis of variance.
Fig.2: mRNA expression of JHDM2A. Men with normal spermatogenesis (n=12, score 10), men with qualitatively normal spermatogenesis 
(n=16, scores 8-9), and in azoospermic men with impaired spermatogenesis (n=34, scores  1-7). Values are presented as mean ± SD. 
SD; Standard deviation.
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Fig.3: A. Scatter plots of CT of mRNA level of YBX2 (r=-0.7; p<0.001) and B. CT of mRNA level of JHDM2A (r=-0.4; p= 0.06). mRNA against 
score value for efficiency of spermatogenesis with regression lines. 
CT;  Threshold cycle.
Fig.4: Typical photomicrographs of hematoxcylin and eosin (H&E) staining of tissues, magnification ×1000. A. Hyospermatogenesis, B. 
Maturation arrest in round spermatid stage, C. Maturation arrest in spermatocyt  stage and D. Maturation arrest in spermatogony stage.
A
C D
B
A B
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Discussion
Generally 5% of adult human males are affect-
ed by male infertility, whereas, 75% are diag-
nosed as idiopathic due to unknown molecular 
mechanisms underlying the defects (12). Sper-
matogenic cells are known through regulated 
spatiotemporal gene expression and strongly re-
pressed translation in meiotic and haploid male 
germ cells. A vast variety of molecules and pro-
teins are involved in these processes (13, 14). 
In this research, we investigated two of these 
important molecules (YBX2 and JHDM2A). The 
proteins encoded by these two genes express 
specifically and highly in testicular tissue and 
are involved in functional regulation of some 
strategicmeiotic and post meiotic genes. Contrin 
(YBX2) is a transcription and translation regu-
latory factor and a germ-cell-specific molecule 
which is essential for the production of func-
tional spermatozoa.
About the molecular function of this protein, an-
imal models and in vitro assay studies showed that 
MSY2 acts as a transcription factor and an mRNA 
stabilizer which regulates expression of some tes-
tis specific genes in transcription and translation 
level. In this regard, MSY2 marks specific mR-
NAs (those transcribed from Y-box promoters) in 
the nucleus for cytoplasmic storage, thereby links 
mRNA transcription and storage/translational de-
lay. In this process, MSY2 recognizes the CTG 
ATTGGC/ TC/TAA sequence as a DNA motif in 
the promoter of many genes that are specifically 
expressed in male germ cells. After MSY2 binds 
to its consensus promoter sequence, binds to tran-
scripts of this gene. Subsequently this protein 
stabilizes and represses their translation as RNA-
protein complexes (15-17).
Yang et al. (18) generated Msy2-null mice. They 
found that the mutant males had an abnormally 
high number of apoptotic meiotic spermatocytes, 
lacked spermatozoa in the epididymis, and were 
sterile. Their results emphasized on the major 
role of this protein in male fertility. Meng et al. 
(19) and Deng et al. (20) reported single nucleo-
tide polymorphisms (SNP) of this gene in China’s 
population, while SNP frequency was significantly 
higher in infertile men compared to fertile ones. 
In other study, Hammoud et al. (21) investigated 
YBX2 gene alterations in blood samples of men 
with severe defects in spermatogenesis, including 
azoospermia, severe oligozoospermia, and abnor-
mal protamine expression. Their results showed 
seven polymorphisms were present at a statisti-
cally higher frequency in patients with infertility, 
particularly in men with abnormal protamine ex-
pression. This study showed t hat YBX2 gene has 
a potential role in male spermatogenesis, leading 
to male factor infertility (21). Our results, in the 
same path, showed significant down-regulation of 
this gene in testicular tissues of azoospermic men 
with impaired spermatogenesis compared to men 
with normal spermatogenesis (p<0.001) (Fig.1A, 
Table 2). There is asignificant negative correlation 
between the score for efficiency of spermatogene-
sis and the mean CT value of mRNA level of YBX2 
in our samples, indicating the role of this gene in 
human spermatogenesis. Other regulatory factor 
which was studied in this research was JHDM2A 
gene. Okada et al. (22) originally cloned this gene 
as a testis-specific gene transcript. Their results 
showed an intense nuclear expression of this gene 
in round spermatids and a sub-nuclear distribution. 
Co-expression of JHDM2A gene with RNA poly-
merase II indicates that this gene may contribute 
to transcriptional activation of some testis specific 
genes. JHDM2A also stimulates TNP1 and PRM 1 
genes, by bonding to core promoter and remov-
ing H3K9 methylation. Histone demethylase JH-
DM2A is critical for Tnp1 and PRM 1 transcription 
and spermatogenesis (22). Jhdm2a-deficient mice 
have shown infertility and smaller testes (23). De-
spite the fact that animal model studies showed the 
role of this protein in male infertility, expression 
ratio of this gene did not show significant differ-
ence between azoospermic and fertile men sam-
ples (p>0.05). Despite the negative correlation be-
tween the efficiency score of spermatogenesis and 
the mean CT value of mRNA level of JHDM2A 
in studied samples, this correlation was not sig-
nificant. Probably the role of this gene is not very 
influential in human fertility; therefore, more sam-
ples must be studied.
Conclusion
Our findings indicated significant down-regula-
tion of YBX2 gene in testis tissue of azoospermic 
men, but future studies are needed to investigate 
the role of YBX2 and JHDM2A genes in regulating 
some specific genes of testis involving in human 
meiotic and post meiotic.   
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